Ethics, Economics, and the Use of Primaquine to Reduce Falciparum Malaria Transmission in Asymptomatic Populations

article has not abstract

Vyšlo v časopise: Ethics, Economics, and the Use of Primaquine to Reduce Falciparum Malaria Transmission in Asymptomatic Populations. PLoS Med 11(8): e32767. doi:10.1371/journal.pmed.1001704
Kategorie: Essay
prolekare.web.journal.doi_sk: 10.1371/journal.pmed.1001704


article has not abstract


1. PurdyM, RobinsonM, WeiK, RublinD (2013) The economic case for combating malaria. Am J Trop Med Hyg 89: 819.

2. OkellLC, BousemaT, GriffinJT, OuedraogoAL, GhaniAC, et al. (2012) Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun 3: 1237.

3. EziefulaAC, GoslingR, HwangJ, HsiangMS, BousemaT, et al. (2012) Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar J 11: 360.

4. GoslingRD, OkellL, MoshaJ, ChandramohanD (2011) The role of antimalarial treatment in the elimination of malaria. Clin Microbiol Infect 17: 1617–1623.

5. MaudeRJ, SocheatD, NguonC, SarothP, DaraP, et al. (2012) Optimising strategies for Plasmodium falciparum malaria elimination in cambodia: Primaquine, mass drug administration and artemisinin resistance. PLoS One 7: e37166.

6. WhiteNJ (2008) The role of anti-malarial drugs in eliminating malaria. Malar J 7 Suppl 1S8.

7. WhiteNJ (2013) Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis 13: 175–181.

8. HowesRE, PielFB, PatilAP, NyangiriOA, GethingPW, et al. (2012) G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 9: e1001339.

9. World Health Organization Evidence Review Group (2012) The safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide. Available: Accessed 08 January 2014

10. KondrashinA, BaranovaAM, AshleyEA, RechtJ, WhiteNJ, et al. (2014) Mass primaquine treatment to eliminate vivax malaria: lessons from the past. Malar J 13: 51.

11. WHO (2013) World Malaria Report 2013. Geneva. Available: Accessed 08 January 2014.

12. KewOM, SutterRW, de GourvilleEM, DowdleWR, PallanschMA (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59: 587–635.

13. LaneJM, RubenFL, NeffJM, MillarJD (1969) Complications of smallpox vaccination, 1968. N Engl J Med 281: 1201–1208.

14. TaylorWR, WhiteNJ (2004) Antimalarial drug toxicity: A review. Drug Saf 27: 25–61.

15. KassNE (2001) An ethics framework for public health. Am J Public Health 91: 1776–1782.

16. BairdJK, SurjadjajaC (2011) Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol 27: 11–16.

17. HowesRE, DewiM, PielFB, MonteiroWM, BattleKE, et al. (2013) Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J 12: 418.

18. GreenoughP (1995) Intimidation, coercion and resistance in the final stages of the South Asian Smallpox Eradication Campaign, 1973–1975. Soc Sci Med 41: 633–645.

19. O'NeillO (2004) Informed consent and public health. Philosophical transactions of the Royal Society of London Series B, Biological sciences 359: 1133–1136.

20. SelgelidMJ (2008) Ethics, tuberculosis and globalization. Public Health Ethics 1: 10–20.

21. WhiteNJ (2010) Artemisinin resistance—the clock is ticking. Lancet 376: 2051–2052.

22. SchefflerS (1982) The Rejection of Consequentialism. 198 8) Consequentialism and Its Critics (Oxford: Oxford University Press)(1992a) Human Morality (Oxford: Oxford University Press) (1992b) “Prerogatives Without Restrictions,”. Philosophical Perspectives 6: 215–239.

23. WMA (2008) WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. 59th WMA General Assembly, Seoul, Korea: World Medical Association.

24. WheelerR (2012) The numeric threshold for the disclosure of risk: outdated and inapplicable to surgical consent. Ann R Coll Surg Engl 94: 81–82.

25. SomervilleMA (1980) Structuring the issues in informed consent. McGill LJ 26: 740.

26. MarshV, KamuyaD, RowaY, GikonyoC, MolyneuxS (2008) Beginning community engagement at a busy biomedical research programme: experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya. Social science & medicine 67: 721–733.

27. HoyerS, NguonS, KimS, HabibN, KhimN, et al. (2012) Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia. PLoS One 7: e45797.

Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine

2014 Číslo 8
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz

Betablokátory a Ca antagonisté z jiného úhlu
Autori: prof. MUDr. Michal Vrablík, Ph.D., MUDr. Petr Janský

Autori: doc. MUDr. Petr Čáp, Ph.D.

Farmakoterapie akutní a chronické bolesti

Získaná hemofilie - Povědomí o nemoci a její diagnostika

Všetky kurzy
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.


Nemáte účet?  Registrujte sa